Skip to content

Insider · CIK 0002121389

Awny Samaan Botros Farajallah

officer

Files at TAK (TAKEDA PHARMACEUTICAL CO LTD). First filing Aug 12, 2026, latest Aug 12, 2026.

In brief

Awny Samaan Botros Farajallah files SEC Form 4 as officer at TAK (TAKEDA PHARMACEUTICAL CO LTD). Since Aug 12, 2026, Awny Samaan Botros Farajallah has reported 0 open-market buys worth $0 and 1 open-market sell worth $240k, the latest filed on Aug 12, 2026.

A track record needs three past buys with six months of prices behind them; Awny Samaan Botros Farajallah has 0, so none is measured yet.

The newest scored trade: sold $240k of TAK on Aug 10, 2026, filed Aug 12, 2026, scored 48 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $240k.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $240k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

TAK: TAKEDA PHARMACEUTICAL CO LTD

TAKOct 9, 2026 · close 18.73

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
48Moderate
TAKsell 13
TAKEDA PHARMACEUTICAL CO LTD
$240k
14,006 shares
-11%+33% from low-7% from high

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Jul 13, 2026 TAK
Takeda Pharmaceutical Company Limited
15,188
0.01% of outstanding
$254kJul 13, 2026none

Transactions

Every row this insider has filed, 2 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Aug 10, 2026TAK
TAKEDA PHARMACEUTICAL CO LTD
SOpen-market sale
American Depositary Shares
-14,006$17.10$240k116,177Aug 12, 2026
Jul 1, 2026TAK
TAKEDA PHARMACEUTICAL CO LTD
AGrant or award
American Depositary Shares
+17,554$0.00$0130,183Jul 6, 2026

Questions about Awny Samaan Botros Farajallah

Answered from the filings on this page, as of the latest one.

Is Awny Samaan Botros Farajallah buying or selling?

In the last 12 months Awny Samaan Botros Farajallah reported 0 open-market buys worth $0 and 1 open-market sell worth $240k on SEC Form 4; the latest was sold $240k of TAK on Aug 10, 2026. Grants, option exercises and tax withholding are not counted.

How did Awny Samaan Botros Farajallah's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Awny Samaan Botros Farajallah has 0.

Where does Awny Samaan Botros Farajallah file Form 4?

Awny Samaan Botros Farajallah has filed Form 4 at TAK (TAKEDA PHARMACEUTICAL CO LTD) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Awny Samaan Botros Farajallah: insider trades and track record | InsiderTell